CPS-EG Score

1 clinical trials · Condition

Record	Firm	Date
A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery (NCT01864746)	GBG Forschungs GmbH	2013-10-30

Every clearance here is in the API, with alerts when new ones post.